These results may derive from a poor selection of candidates for treatment, generally based on PD-L1 expression, along with the potential involvement of tumor-intrinsic mechanisms of primary resistance, such as defective antigen presentation and promotion of an immunosuppressive tumor microenvironment [2]. This evidence concerns the gene CD274 and neoplasm.